College of American Pathologists Consensus Conference XXXVI: Diagnostic issues in thrombophilia - Introduction and general considerations

Archives of Pathology and Laboratory Medicine

Volumn 126, Issue 11, 2002, Pages 1277-1280

  Olson, John D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; LABORATORY TEST; MEDICAL LITERATURE; MEDICAL SOCIETY; PATHOLOGIST; PRACTICE GUIDELINE; PUBLICATION; RISK ASSESSMENT; THROMBOPHILIA; THROMBOSIS;

BLOOD COAGULATION TESTS; EVIDENCE-BASED MEDICINE; HUMANS; PATHOLOGY, CLINICAL; THROMBOPHILIA;

EID: 0036881555     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Meyer M. Report of the President to the XVIII Congress of the International Society on Thrombosis and Haemostasis. Presented at: Annual Meeting of the International Society on Thrombosis and Haemostasis; July 10, 2001; Paris, France.
2. McKenzie SB, Clare CN, Smith LA, Lee Sang JE. Laboratory test utilization in the diagnosis of hypercoagulability. Clin Lab Sci. 2000;13:215-221.
3. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med. 2002;126:1304-1318.
4. McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med. 2002;126:1319-1325.
5. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med. 2002;126:1326-1336.
6. Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002;126:1337-1348.
7. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill EG. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126:1349-1366.
8. Key NS, McGlennen RC. Hyperhomocyst(e)inemia and thrombophilia. Arch Pathol Lab Med. 2002;126:1367-1375.
9. Brandt JT. Plasminogen and tissue plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med. 2002;126:1376-1381.
10. Kitchens CS. The contact system. Arch Pathol Lab Med. 2002;126:1382-1386.
11. Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med. 2002; 126:1387-1390.
12. Francis CW. Factor XIII polymorphisms and venous thromboembolism. Arch Pathol Lab Med. 2002;126:1391-1393.
13. Tollefsen DM. Heparin cofactor II deficiency. Arch Pathol Lab Med. 2002; 126:1394-1400.
14. Francis CW. Plasminogen activator inhibitor-1 levels and polymorphisms: association with venous thromboembolism. Arch Pathol Lab Med. 2002;126: 1401-1404.
15. Chandler WL, Rodgers GM, Sprouse JT, Thompson AR. Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med. 2002; 126:1405-1414.
16. Warkentin TE. Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia: recommendations of the College of American Pathologists. Arch Pathol Lab Med. 2002;126:1415-1423.
17. Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med. 2002;126: 1424-1429.
18. Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Arch Pathol Lab Med. 2002;126:1430-1433.
19. Van Cott EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis: venous thromboembolism, myocardial infarction, stroke, and other conditions. Arch Pathol Lab Med. 2002;126: 1281-1295.
20. Brenner BR, Nowak-Göttl U, Kosch A, Manco-Johnson M, Laposata M. Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med. 2002;126:1296-1303.
21. Participant Summary Report. CED-C. Northfield, III: College of American Pathologists; 2001.